Effect Of Dashmooladi Siddha Ksheerdhara And Dashmooladi Kwatha Oral Administration In Tension Type Headache.

A Comparative Clinical Study To Evaluate The Efficacy Of Dashmooladi Siddha Ksheerdhara And Dashmooladi Kwatha Oral Administration In The Management Of Vataja Shirorog With Special Reference To Tension Type Headache. - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/02/062874

Enrollment

Registered

2024-02-19

Start date

Unknown

Completion date

Unknown

Last updated

2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G442- Tension-type headache

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients aged between 18-70 years irrespective of their gender. 2.Patients presenting with signs and symptoms of Vataja shirorog described as per Ayurvedic literature. 3.Patients having signs and symptoms of tension type headache as per modern literature. 4.Professional stress leading to tension type headache.

Exclusion criteria

Exclusion criteria: 1.Individual age more than 70 years and less than 18 years. 2Patients having signs and symptoms other than Vatika shiroroga( tension type headache). 3.Patients having any immunocompromised disease such as hypertension, diabetes mellitus, tuberculosis, cancer or any other major disease. 4.Patients associated with history of head injury. 5.Secondary headache caused by sinus headache, meningitis, encephalitis, cervical spondylitis, refractive error and increased intra ocular pressure. 6.Patients suffering from major psychotic or neurological disorders. 7.Patients suffering from disorders of eye, ent, and dental diseases. 8.Patients of head tumor or surgical abnormalities associated with headache. 9.Patients having headache due to ajeerna (indigestion). 10.Patients having chronic tension type headache.

Design outcomes

Primary

Measure	Time frame
Decrease in signs and symptoms.Timepoint: 14th day	—

Secondary

Measure	Time frame
Decreased episodes of pain and improve quality of life of patientsTimepoint: 28th day	—

Countries

India

Contacts

Public ContactDr Ajay Kumar

Government P.G. Ayurveda College and Hospital Varanasi

drajay2000@gmail.com9616870871

Outcome results